Illumina Body Map 2: averaged replicates
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PAX5 | hg19_v2_chr9_-_37034028_37034157 | 0.81 | 2.5e-08 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_23101182 Show fit | 5.18 |
ENST00000390312.2
|
immunoglobulin lambda variable 2-14 |
|
chr2_+_89986318 Show fit | 5.00 |
ENST00000491977.1
|
immunoglobulin kappa variable 2D-29 |
|
chr14_-_107170409 Show fit | 4.81 |
ENST00000390633.2
|
immunoglobulin heavy variable 1-69 |
|
chr14_-_106539557 Show fit | 4.80 |
ENST00000390599.2
|
immunoglobulin heavy variable 1-8 |
|
chr22_+_23165153 Show fit | 4.73 |
ENST00000390317.2
|
immunoglobulin lambda variable 2-8 |
|
chr22_+_22930626 Show fit | 4.72 |
ENST00000390302.2
|
immunoglobulin lambda variable 2-33 (non-functional) |
|
chr22_+_23040274 Show fit | 4.42 |
ENST00000390306.2
|
immunoglobulin lambda variable 2-23 |
|
chr22_+_22385332 Show fit | 4.08 |
ENST00000390282.2
|
immunoglobulin lambda variable 4-69 |
|
chr22_-_37882395 Show fit | 4.07 |
ENST00000416983.3
ENST00000424765.2 ENST00000356998.3 |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
chr14_-_106069247 Show fit | 3.89 |
ENST00000479229.1
|
RP11-731F5.1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 139.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.4 | 85.3 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 36.3 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 32.0 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.2 | 16.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 13.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.6 | 12.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.3 | 12.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.1 | 12.1 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 10.4 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 52.8 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 47.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 20.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 20.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 18.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.5 | 17.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 17.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.2 | 17.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 15.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 15.0 | GO:0001891 | phagocytic cup(GO:0001891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 174.4 | GO:0003823 | antigen binding(GO:0003823) |
0.9 | 61.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 21.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 19.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.4 | 13.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.1 | 9.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.2 | 9.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 8.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.5 | 6.8 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 6.6 | GO:0019863 | IgE binding(GO:0019863) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 29.8 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.3 | 27.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 20.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 11.1 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.3 | 10.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.2 | 10.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 9.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 9.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 8.6 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.2 | 7.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 36.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 21.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 17.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 15.6 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 11.4 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 9.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 8.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.2 | 6.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 5.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |